AIM 11 September 2024 NOTICE 11/09/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the Company the...
BiVictriX Therapeutics PLC 10 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91...
BiVictriX Therapeutics PLC 10 September 2024 BiVictriX Therapeutics plc ("BiVictriX", "BiVictriX Therapeutics" or the "Company") Last Day...
Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid ...
BiVictriX Therapeutics PLC 09 September 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No...
BiVictriX Therapeutics PLC 02 September 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91...
BiVictriX Therapeutics PLC 02 September 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET...
BiVictriX Therapeutics PLC 29 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No...
BiVictriX Therapeutics PLC 28 August 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer...
BiVictriX Therapeutics PLC 19 August 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent...
BiVictriX Therapeutics PLC 13 August 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE...
Bivictrix Therapeutics PLC on Monday announced its intention to delist from AIM in favour of pursuing funding as a pr ...
BiVictriX Therapeutics PLC 12 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No...
BiVictriX Therapeutics PLC 01 August 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET...
Support
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads